Volitionrx (VNRX) Total Current Liabilities (2011 - 2026)
Volitionrx's (VNRX) quarterly Total Current Liabilities came in at $12.2 million in Q4 2025, up 56.99% YoY from $7.8 million in Q4 2024, and up 7.08% on a QoQ basis from $11.4 million in Q3 2025.
Volitionrx (VNRX) Total Current Liabilities (2011 - 2026) Analysis & Trends
Volitionrx (VNRX) has 11 years of Total Current Liabilities data on file, last reported at $12.2 million in Q4 2025.
- Quarterly Total Current Liabilities rose 56.99% year-over-year to $12.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.2 million (up 56.99% YoY) and the FY2025 annual result came in at $12.2 million, up 56.99% from the prior year.
- Total Current Liabilities rose to $12.2 million in Q4 2025, from $11.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $31.5 million in Q1 2024 to a low of $5.4 million in Q2 2021.
- A 5-year average of $15.3 million and a median of $17.0 million in 2022 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 221.42% — and 2025, when it sank 73.73%.
- Tracing VNRX's Total Current Liabilities over 5 years: stood at $6.5 million in 2021, then surged by 166.83% to $17.4 million in 2022, then slumped by 48.56% to $8.9 million in 2023, then declined by 12.89% to $7.8 million in 2024, then surged by 56.99% to $12.2 million in 2025.
- The last three Total Current Liabilities figures came in at $12.2 million (Q4 2025), $11.4 million (Q3 2025), and $9.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Volitionrx | 1.19 Mn | -1.60 Mn | - | 13.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.49 Mn |
| Dec 31, 2025 | 12.23 Mn |
| Sep 30, 2025 | 11.42 Mn |
| Jun 30, 2025 | 9.24 Mn |
| Mar 31, 2025 | 8.27 Mn |
| Dec 31, 2024 | 7.79 Mn |
| Sep 30, 2024 | 30.28 Mn |
| Jun 30, 2024 | 30.98 Mn |
| Mar 31, 2024 | 31.49 Mn |
| Dec 31, 2023 | 8.94 Mn |
| Sep 30, 2023 | 17.65 Mn |
| Jun 30, 2023 | 18.80 Mn |
| Mar 31, 2023 | 17.24 Mn |
| Dec 31, 2022 | 17.39 Mn |
| Sep 30, 2022 | 16.98 Mn |
| Jun 30, 2022 | 17.35 Mn |
| Mar 31, 2022 | 17.51 Mn |
| Dec 31, 2021 | 6.52 Mn |
| Sep 30, 2021 | 5.85 Mn |
| Jun 30, 2021 | 5.40 Mn |